Literature DB >> 26578075

Gabapentin Use in the Neonatal Intensive Care Unit.

Laura Edwards1, Stephen DeMeo1, Chi D Hornik2, C Michael Cotten1, P Brian Smith1, Carolyn Pizoli3, Julie M Hauer4, Margarita Bidegain5.   

Abstract

Gabapentin was used for the treatment of term and preterm infants with suspected visceral hyperalgesia caused by a variety of neurologic and gastrointestinal morbidities. Improved feeding tolerance and decreased irritability were seen, as well as decreased usage of opioids and benzodiazepines. Adverse events occurred with abrupt discontinuation of this medication.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26578075      PMCID： PMC4729593          DOI： 10.1016/j.jpeds.2015.10.013

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  10 in total

1.  Gabapentin withdrawal syndrome.

Authors:  J W Norton
Journal:  Clin Neuropharmacol       Date:  2001 Jul-Aug       Impact factor: 1.592

2.  Treatment of pain with gabapentin in a neonate.

Authors:  M O Behm; G L Kearns
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

Review 3.  Visceral hypersensitivity.

Authors:  Silvia Delgado-Aros; Michael Camilleri
Journal:  J Clin Gastroenterol       Date:  2005 May-Jun       Impact factor: 3.062

4.  Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment.

Authors:  Julie M Hauer; Beverly S Wical; Lawrence Charnas
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

Review 5.  Gabapentin.

Authors:  G L Morris
Journal:  Epilepsia       Date:  1999       Impact factor: 5.864

6.  Treatment with gabapentin associated with resolution of apnea in two infants with neurologic impairment.

Authors:  Julie Hauer; Daniel Mackey
Journal:  J Palliat Med       Date:  2012-08-07       Impact factor: 2.947

7.  Single-dose gabapentin pharmacokinetics and safety in healthy infants and children.

Authors:  G M Haig; H N Bockbrader; D L Wesche; S W Boellner; D Ouellet; R R Brown; E J Randinitis; E L Posvar
Journal:  J Clin Pharmacol       Date:  2001-05       Impact factor: 3.126

8.  Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

Authors:  K O Vollmer; A von Hodenberg; E U Kölle
Journal:  Arzneimittelforschung       Date:  1986-05

Review 9.  Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans.

Authors:  H Mertz
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Gabapentin therapy for pain and irritability in a neurologically impaired infant.

Authors:  A Lauren Haney; Sandra S Garner; Toby H Cox
Journal:  Pharmacotherapy       Date:  2009-08       Impact factor: 4.705
  10 in total
  12 in total

1.  The Use of Gabapentin for Pain and Agitation in Neonates and Infants in a Neonatal ICU.

Authors:  Gretchen L Sacha; Maria G Foreman; Kay Kyllonen; Ricardo J Rodriguez
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

2.  Gabapentin Use for Hospitalized Neonates.

Authors:  Hibo H Abdi; Nathalie L Maitre; Kristen L Benninger; Mark E Hester; Jonathan L Slaughter
Journal:  Pediatr Neurol       Date:  2019-02-21       Impact factor: 3.372

Review 3.  Novel Approaches for Treating Pain in Children.

Authors:  William Splinter
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

4.  Gabapentin Improves Oral Feeding in Neurologically Intact Infants With Abdominal Disorders.

Authors:  Keliana L O'Mara; Saleem Islam; Janice A Taylor; Daniel Solomon; Michael D Weiss
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jan-Feb

Review 5.  Managing Procedural Pain in the Neonate Using an Opioid-sparing Approach.

Authors:  Anthony Squillaro; Elaa M Mahdi; Nhu Tran; Ashwini Lakshmanan; Eugene Kim; Lorraine I Kelley-Quon
Journal:  Clin Ther       Date:  2019-08-17       Impact factor: 3.393

Review 6.  [Pediatric pain treatment and prevention for hospitalized children].

Authors:  Stefan J Friedrichsdorf; Liesbet Goubert
Journal:  Schmerz       Date:  2020-12-18       Impact factor: 1.107

Review 7.  Chronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head, Abdomen, Muscles and Joints.

Authors:  Stefan J Friedrichsdorf; James Giordano; Kavita Desai Dakoji; Andrew Warmuth; Cyndee Daughtry; Craig A Schulz
Journal:  Children (Basel)       Date:  2016-12-10

8.  Pain reporting and analgesia management in 270 children with a progressive neurologic, metabolic or chromosomally based condition with impairment of the central nervous system: cross-sectional, baseline results from an observational, longitudinal study.

Authors:  Stefan J Friedrichsdorf; Andrea C Postier; Gail S Andrews; Karen Es Hamre; Rose Steele; Harold Siden
Journal:  J Pain Res       Date:  2017-07-31       Impact factor: 3.133

9.  Visceral Hyperalgesia: When to Consider Gabapentin Use in Neonates-Case Study and Review.

Authors:  Joseph Asaro; Christine A Robinson; Philip T Levy
Journal:  Child Neurol Open       Date:  2017-02-10

10.  Stability of gabapentin in extemporaneously compounded oral suspensions.

Authors:  Mihaela Friciu; V Gaëlle Roullin; Grégoire Leclair
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.